Figure 1A.

Figure 1A.Figure 1. Facilitation of exposure-based psychotherapy by D-cycloserine (DCS) in patients with fear of heights (A); social phobia (B); obsessive-compulsive disorder (C), or panic disorder (D).. From: NMDA receptors and fear extinction: implications for cognitive behavioral therapy.

Reproduced from ref 74: Ressler KJ, Rothbaum BO, Tannenbaum L, et al. Cognitive enhancers as adjuncts to psychotherapy: use of D-cycloserine in phobic individuals to facilitate extinction of fear Arch Gen Psychiatry. 2004:61:1136-1144. Copyright © American Medical Association 2004: ref 77: Hofmann SG, Meuret AE, Smits JA, et al. Augmentation of exposure therapy with D-cycloserine for social anxiety disorder. Arch Gen Psychiatry. 2006:63:298-304. Copyright © American Medical Association 2006: ref 79: Wilhelm S, Buhlmann U, Tolin DF, et al. Augmentation of behavior therapy with D-cycloserine for obsessive-compulsive disorder. Am J Psychiatry. 2008:165:335-341: quiz 409. Copyright © Hanover 2008: ref 80: Otto MW, Tolin DF, Simon NM.etal. Efficacy of dcycloserine for enhancing response to cognitive-behavior therapy for panic disorder. Biol Psychiatry. 2010:67:365-370. Copyright © Elsevier 2010

Michael Davis. Dialogues Clin Neurosci. 2011 December;13(4):463-474.

Supplemental Content

Filter your results:

Search details

See more...

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Write to the Help Desk